Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Pregabalin ER Formulations
NCT02725112Phase 1Completed
- Sponsor
- Viatris
- Start
- Feb 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pregabalin in neuropathic pain (6 arms), sponsored by Viatris. Primary endpoints: Maximum Observed Plasma Concentration at 10 weeks and Area Under the Curve at 10 weeks. Started Feb 2016; status: completed.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02725112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02725112.